Latest & greatest articles for insomnia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on insomnia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on insomnia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for insomnia

441. Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomised controlled trial. Full Text available with Trip Pro

63 obese men (body mass index 30-40, age 30-65 years) with moderate to severe obstructive sleep apnoea (apnoea-hypopnoea index (AHI) >or=15), treated with continuous positive airway pressure.The intervention group received a liquid very low energy diet (2.3 MJ/day) for seven weeks to promote weight loss, followed by two weeks of gradual introduction of normal food, reaching 6.3 MJ/day at week 9. The control group adhered to their usual diet during the nine weeks of follow-up.AHI, the major (...) Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomised controlled trial. To assess the effect of weight loss induced by a very low energy diet on moderate and severe obstructive sleep apnoea in obese men. Design Single centre, two arm, parallel, randomised, controlled, open label trial. Blocked randomisation procedure used for treatment allocation. Setting Outpatient obesity clinic in a university hospital in Stockholm, Sweden. Participants

2009 BMJ Controlled trial quality: predicted high

442. Nurse-led care was non-inferior to physician-directed care in symptomatic moderate to severe obstructive sleep apnoea

Nurse-led care was non-inferior to physician-directed care in symptomatic moderate to severe obstructive sleep apnoea Nurse-led care was non-inferior to physician-directed care in symptomatic moderate to severe obstructive sleep apnoeaCommentary | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) Nurse-led care was non-inferior to physician-directed care in symptomatic moderate to severe obstructive sleep apnoea Commentary Statistics from Altmetric.com Question Is nurse-led care non-inferior to physician-directed care in patients with symptomatic moderate to severe obstructive sleep apnoea (OSA)? Methods Design: randomised controlled trial (RCT). ACTRN 012605000064606. Allocation: concealed. Blinding: blinded (research assistants). Follow-up period: 3 months. Setting: 3 academic sleep

2009 Evidence-Based Nursing

443. A very low calorie diet plus lifestyle counselling improved mild obstructive sleep apnoea in overweight patients

A very low calorie diet plus lifestyle counselling improved mild obstructive sleep apnoea in overweight patients A very low calorie diet plus lifestyle counselling improved mild obstructive sleep apnoea in overweight patientsCommentary | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here A very low calorie diet plus lifestyle counselling improved mild obstructive sleep apnoea in overweight patientsCommentary Article Text Treatment A very low calorie

2009 Evidence-Based Nursing

444. Review: continuous positive airway pressure devices are effective and cost-effective for obstructive sleep apnoea

airway pressure devices are effective and cost-effective for obstructive sleep apnoea Statistics from Altmetric.com Question Are continuous positive airway pressure (CPAP) devices effective and cost-effective for treatment of obstructive sleep apnoea-hypopnoea syndrome (OSAHS)? Review scope Included studies compared CPAP devices (used for ⩾1 wk) with placebo, supportive or usual care, or dental devices in adults (⩾16 y of age) with OSAHS. Studies in patients with central nervous system dysfunction (...) Review: continuous positive airway pressure devices are effective and cost-effective for obstructive sleep apnoea Review: continuous positive airway pressure devices are effective and cost-effective for obstructive sleep apnoea | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username

2009 Evidence-Based Medicine

445. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis

Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis McDaid C, Griffin S, Weatherly H, Duree K (...) sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technology Assessment 2009; 13(4): 1-274 PubMedID DOI Original Paper URL Other URL Link to record in NHS EED: Link to record in HTA database: Additional Data URL Other publications of related interest Giles TL, Lasserson TJ, Smith BJ, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database of Systematic Reviews 2006;3:Art. No.: CD001106. DOI: 10.1002

2009 DARE.

446. Updated systematic review of tonsillectomy and adenoidectomy for treatment of pediatric obstructive sleep apnea/hypopnea syndrome

Updated systematic review of tonsillectomy and adenoidectomy for treatment of pediatric obstructive sleep apnea/hypopnea syndrome Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

447. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis

Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

448. Self-help therapy for insomnia: a meta-analysis

Self-help therapy for insomnia: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

449. A systematic review of the effects of acupuncture in treating insomnia

A systematic review of the effects of acupuncture in treating insomnia Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

450. Effects and side-effects of surgery for snoring and obstructive sleep apnea: a systematic review

searched in September 2007 for studies in English. Search terms were reported. Reference lists of articles retrieved were checked. Study selection Randomised controlled trials (RCTs) that compared the effectiveness of surgery versus sham surgery or conservative treatment for snoring or obstructive sleep apnoea in adults were eligible for inclusion. Primary review outcomes were daytime sleepiness (measured with the Epworth Sleepiness Scale, Multiple Sleep Latency test or Maintenance of Wakefulness test (...) that controls could be randomised to delayed surgery rather than placebo and recommended blinding of outcomes assessment (at least). Funding No external or industry funding. Bibliographic details Franklin KA, Anttila H, Axelsson S, Gislason T, Maasilta P, Myhre KI, Rehnqvist N. Effects and side-effects of surgery for snoring and obstructive sleep apnea: a systematic review. Sleep 2009; 32(1): 27-36 PubMedID Original Paper URL Other URL Indexing Status Subject indexing assigned by NLM MeSH Adult; Disorders

2009 DARE.

451. A meta-analysis of the effects of atrial overdrive pacing on sleep apnea syndrome

A meta-analysis of the effects of atrial overdrive pacing on sleep apnea syndrome Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

452. Acupuncture for treatment of insomnia: a systematic review of randomized controlled trials

Acupuncture for treatment of insomnia: a systematic review of randomized controlled trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

453. Traditional needle acupuncture treatment for insomnia: a systematic review of randomized controlled trials

Traditional needle acupuncture treatment for insomnia: a systematic review of randomized controlled trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

454. Portable monitoring devices for diagnosis of obstructive sleep apnea at home: review of accuracy, cost effectiveness, guidelines, and coverage in Canada

Portable monitoring devices for diagnosis of obstructive sleep apnea at home: review of accuracy, cost effectiveness, guidelines, and coverage in Canada Portable monitoring devices for diagnosis of obstructive sleep apnea at home: review of accuracy, cost effectiveness, guidelines, and coverage in Canada Portable monitoring devices for diagnosis of obstructive sleep apnea at home: review of accuracy, cost effectiveness, guidelines, and coverage in Canada Ndegwa S, Clark M, Argaez C Record (...) Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Ndegwa S, Clark M, Argaez C. Portable monitoring devices for diagnosis of obstructive sleep apnea at home: review of accuracy, cost effectiveness, guidelines, and coverage in Canada . Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). 2009 Authors' objectives To review evidence

2009 Health Technology Assessment (HTA) Database.

455. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. (Abstract)

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Circadian rhythm sleep disorders are common causes of insomnia for millions of individuals. We did a phase II study to establish efficacy and physiological mechanism, and a phase III study to confirm efficacy of the melatonin agonist tasimelteon (VEC-162) for treatment of transient insomnia associated with shifted sleep and wake time.We undertook phase II (...) healthy individuals from 19 US sites, who had transient insomnia induced in a sleep clinic by a 5-h advance of the sleep-wake schedule and a first-night effect in a sleep clinic, were given tasimelteon (20 [n=100], 50 [n=102], or 100 mg [n=106]) or placebo (n=103) 30 min before bedtime. Prespecified primary efficacy outcomes were polysomnographic sleep efficiency (phase II study), latency to persistent sleep (phase III study), and circadian phase shifting (phase II study). Analysis was by intention

2009 Lancet Controlled trial quality: predicted high

456. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. Full Text available with Trip Pro

of maintenance therapies on long-term outcome.Prospective, randomized controlled trial involving 2-stage therapy for 160 adults with persistent insomnia treated at a university hospital sleep center in Canada between January 2002 and April 2005.Participants received CBT alone or CBT plus 10 mg/d (taken at bedtime) of zolpidem for an initial 6-week therapy, followed by extended 6-month therapy. Patients initially treated with CBT attended monthly maintenance CBT for 6 months or received no additional (...) treatment and those initially treated with combined therapy (CBT plus 10 mg/d of zolpidem) continued with CBT plus intermittent use of zolpidem or CBT only.Sleep onset latency, time awake after sleep onset, total sleep time, and sleep efficiency derived from daily diaries (primary outcomes); treatment response and remission rates derived from the Insomnia Severity Index (secondary outcomes).Cognitive behavioral therapy used singly or in combination with zolpidem produced significant improvements

2009 JAMA Controlled trial quality: predicted high

457. An economic analysis of continuous positive airway pressure for the treatment of obstructive sleep apnea-hypopnea syndrome Full Text available with Trip Pro

2006;166:977-84. McDaid C, Griffin S, Weatherly H, et al. Continuous positive airway pressure for the treatment of obstructive sleep apnoea-hypopnoea syndrome: A systematic review and economic analysis. Health Technol Assess 2009;13:4. Indexing Status Subject indexing assigned by NLM MeSH Continuous Positive Airway Pressure /economics; Cost-Benefit Analysis; Great Britain; Humans; Markov Chains; Models, Economic; Models, Statistical; Probability; Sleep Apnea, Obstructive /economics; Treatment Outcome (...) An economic analysis of continuous positive airway pressure for the treatment of obstructive sleep apnea-hypopnea syndrome An economic analysis of continuous positive airway pressure for the treatment of obstructive sleep apnea-hypopnea syndrome An economic analysis of continuous positive airway pressure for the treatment of obstructive sleep apnea-hypopnea syndrome Weatherly H L, Griffin S C, McDaid C, Duree K H, Davies R J, Stradling J R, Westwood M E, Sculpher M J Record Status

2009 NHS Economic Evaluation Database.

458. Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia

data source was a clinical trial. The time horizon was six months and the authors stated that the perspective was that of society. Effectiveness data: The effectiveness data were from a single clinical trial that lasted for six months. The patients had chronic primary insomnia that was diagnosed using the Diagnostic and Statistical Manual of mental disorders (DSM) IV and other sleep criteria. The Insomnia Severity Index (ISI) was used to assess the severity and impact of insomnia symptoms (...) of eszopiclone). Bibliographic details Snedecor SJ, Botteman MF, Bojke C, Schaefer K, Barry N, Pickard AS. Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia. Sleep 2009; 32(6): 817-824 PubMedID Original Paper URL Indexing Status Subject indexing assigned by NLM MeSH Absenteeism; Adult; Azabicyclo Compounds /adverse effects /economics /therapeutic use; Controlled Clinical Trials as Topic; Cost-Benefit Analysis; Double-Blind Method; Drug Costs /statistics & Eszopiclone

2009 NHS Economic Evaluation Database.

459. Obstructive sleep apnoea and its cardiovascular consequences. (Abstract)

Obstructive sleep apnoea and its cardiovascular consequences. Obstructive sleep apnoea (OSA) is a common disorder in which repetitive apnoeas expose the cardiovascular system to cycles of hypoxia, exaggerated negative intrathoracic pressure, and arousals. These noxious stimuli can, in turn, depress myocardial contractility, activate the sympathetic nervous system, raise blood pressure, heart rate, and myocardial wall stress, depress parasympathetic activity, provoke oxidative stress

2008 Lancet

460. EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep.

EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep. Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research Trust Fund You are here Guidelines

2008 European Federation of Neurological Societies